Completed
Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines
NCT03308825
- Conditions
- Flu, Infections, Influenza, +6 more
- Locations
-
- Sanofi Pasteur Investigational Site 003 Council Bluffs, Iowa, United States
- Sanofi Pasteur Investigational Site 002 Bardstown, Kentucky, United States
- Sanofi Pasteur Investigational Site 001 Metairie, Louisiana, United States